Affinity Asset Advisors’s Immunovant IMVT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.48M Sell
100,000
-100,000
-50% -$2.59M 0.15% 91
2025
Q4
$5.08M Sell
200,000
-100,000
-33% -$2.23M 0.37% 65
2025
Q3
$4.84M Buy
+300,000
New +$4.86M 0.45% 52
2025
Q2
Sell
-430,000
Closed -$7.35M 112
2025
Q1
$7.35M Buy
430,000
+330,000
+330% +$6.9M 1.15% 33
2024
Q4
$2.48M Sell
100,000
-125,000
-56% -$3.55M 0.39% 56
2024
Q3
$6.41M Sell
225,000
-121,088
-35% -$3.57M 1% 38
2024
Q2
$9.14M Buy
346,088
+61,088
+21% +$1.74M 1.44% 28
2024
Q1
$9.21M Sell
285,000
-60,000
-17% -$2.19M 1.5% 27
2023
Q4
$14.5M Buy
345,000
+45,000
+15% +$1.66M 2.9% 14
2023
Q3
$11.5M Buy
300,000
+40,000
+15% +$904K 3.76% 10
2023
Q2
$4.93M Buy
+260,000
New +$4.85M 1.94% 20
2021
Q4
Hold
0
67
2021
Q3
Hold
0
86
2021
Q2
Hold
0
79
2021
Q1
Sell
-75,000
Closed -$1.98M 77
2020
Q4
$3.46M Buy
+75,000
New +$3.47M 2.13% 14

Other funds holding IMVT